APOE was able to activate LILRB4 on human monocytic AML cells, where SHP-2 was phosphorylated and NF-kB pathway was subsequently activated, resulting in the upregulation of urokinase receptor (uPAR) and arginase-1 (ARG1). The gene discussed is NFKB1; the disease is acute myeloid leukemia.